This was mainly demonstrated in human colon cancer cells with a mutant KRAS gene, influenced by sodium-dependent vitamin C transporter 2 (SVCT-2) with administration of daily doses of 10 g of L-ascorbic acid for 6 h. The gene discussed is KRAS; the disease is colonic neoplasm.